Novo Nordisk has become the latest pharma group to be targeted by a cyberattack, with the company revealing that some patient ...

Zasocitinib – which is billed by Takeda as a second-generation TYK2 inhibitor – was more effective than Sotyktu ...

"Feeling seen, appreciated, and emotionally supported is not a luxury feature in health AI - it is a condition of access," ...

Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...

The Stem research and interviews with senior Centre of Excellence (CoE) leaders at Boehringer Ingelheim, Takeda, Merck, Novo ...

San Francisco-based SonoThera closed an oversubscribed $125 million Series B financing round, saying it will use the proceeds ...

AI company Anthropic has launched a new large language model (LLM) – Claude Fable 5 – claiming its capabilities as a tool for ...

AbbVie's Aquipta can now be commissioned by the NHS in England and Wales as an acute treatment for migraine, adding to its ...

ADA: Lilly's weight-loss reveal, and wannabes display wares. Lilly reveals more details of its retatrutide obesity and ...

There are around 46,000 new cases of prostate cancer each year in England and Wales, with 13% of these cases showing signs of ...

An AI-designed vaccine against all variants of the coronavirus SARS-CoV-2 – designed using an AI-powered platform developed ...

Fueled by this momentum, the 16th World Clinical Biomarkers & Companion Diagnostics Summit makes its return to Boston, with ...